Actor/neuton

PubMed Articles Scraper

Search PubMed articles by query or PMID and export titles, abstracts, journals, publication dates, authors, DOI, MeSH terms, publication types, and PubMed URLs using NCBI E-utilities.

Publisher description, verbatim
Last 7 dayson this actor
Each one reaches followers by email the morning after.Follow this actor
Key figures10 readings
Price / 1k$1.50per 1,000 results
Users / 30d1→ 0 over 10 readings
Users, all time2→ 0 over 10 readings
Runs / 30d28↓ 1 over 10 readings
Runs / user / mo28.0runs per monthly user
Standing
#31of 70

on PubMed, by users in the last 30 days among actors classified to this platform.

Recorded changes

No price, README, schema or grade changes in the last 30 days · followers get the next one by email.

History

10 readings since 2026-09-09
Users / 30d10 readings
09-09→ 009-25
Users, all time10 readings
09-09→ 009-25
Runs / 30d10 readings
09-09↓ 109-25
Standing19 readings
09-09↑ 609-25

Alternatives on PubMed

The actors either side of #31 of 70, ranked by users in the last 30 days. Same platform, adjacent adoption — the comparable set.

all 70 on PubMed →
Sort
#ActorGradePrice / 1kUsers /30dSuccessRatingAgeFresh
26—RES$10.00 /1kfair price12 total——5maging
27—RES$3.00 /1kfair price12 total——3mfresh
28—RES$10.00 /1kfair price12 total——5maging
29—EVT$7.00 /1k research-search12 total——44dfresh
30—RES$60.00 /1khigh price12 total——3maging
31—RES$1.50 /1kgood price12 total——2mfreshThis
32—EVT$7.00 /1k article-returned12 total——14dfresh
33—RES$100 /1ksteep price12 total——3maging
34—RES$0.50 /1kgood price12 total——45dfresh
35—EVT$4.00 /1k result-item12 total——33dfresh
36—EVT$12.00 /1k result-item114 total—5.0 (1)10mfresh

Follow this actor, compare it against its rivals, and get every overnight change in one morning report.

Publish it yourself? Claim your publisher page and its full history is yours free, forever.

Open in the app Claim this page

Numbers on this page are measured only by an independent census of the Apify Store — not self-reported. Not indexed: too little has happened to this actor for us to have anything worth saying yet.